iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Mankind Pharma Ltd Option Chain

Add as a Preferred Source on Google
2,355
(-1.17%)
Aug 31, 2026|10:49:54 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--2,080₹0.3 0%1,7500%
--2,100₹2.4 0%8,0000%
7500%₹225.05 0%2,140--
2,0000%₹212.95 0%2,160₹5.3 -2.75%8,7500%
5000%₹196.95 0%2,180₹13.05 0%5000%
500100%₹208.3 -10.98%2,200₹9.2 46.03%64,500-8.83%
2,0000%₹197.1 25.66%2,220₹16.55 0%5000%
--2,240₹10 0%9,2500%
00%₹196.8 0%2,260₹19.25 54.61%10,750104.76%
1,00033.33%₹116 -46.76%2,280₹34.8 0%00%
7,75029.16%₹98 -25.27%2,300₹28.75 47.43%1,54,000-2.53%
--2,320₹49.8 0%3,7500%
19,75031.66%₹67 -21.59%2,360₹53.35 42.26%1,44,0000.17%
32,50041.30%₹58.5 -22.46%2,380₹61.95 35.7%22,00025.71%
1,74,00016.19%₹49.75 -24.1%2,400₹74.75 36.52%91,2501.95%
16,7508.06%₹42.6 -23.45%2,420₹65.95 1.93%5,5000%
46,00011.51%₹35.5 -24.78%2,440₹76.9 0.98%5,5000%
18,00020%₹29.05 -26.54%2,460₹118.65 34.44%36,0000%
1,07,00014.74%₹21.6 -22.44%2,500₹141.6 22.27%9,5002.70%
5000%₹67.1 0%2,540--
27,50027.90%₹13.05 -18.18%2,560₹171.95 -14.45%1,00033.33%
2500%₹18 0%2,580₹189.25 -13.52%75050%
3,69,250245.90%₹9.95 -12.71%2,600₹200 0%4,7500%
5000%₹29.4 0%2,620₹216.95 -4.78%5000%
5000%₹22 0%2,640₹236.25 3.43%2,2500%
26,25015.38%₹4.3 -6.52%2,700₹295.3 -7.71%1,0000%
2500%₹22.25 0%2,760--
1,0000%₹3.5 0%2,800₹418 0.23%5000%
00%₹3 0%2,820--
5000%₹1.25 0%2,920--
1,2500%₹1.05 10.52%2,960--

Mankind Pharma: Related NEWS

Mankind Pharma Q1 Updates: Net profit down ~18%

The company also informed that its diluted earnings per share (EPS) slipped by 20.10% on a yearly basis to ₹10.60.

1 Aug 2025|01:41 PM
Read More
Top Stocks for Today - 01st August 2025

Here are some of the stocks that may see significant price movement today: Coal India, Mankind Pharma, Swiggy, etc.

1 Aug 2025|08:58 AM
Read More
Mankind Pharma posts mixed performance in Q4; stock slips ~4%

The business said that it logged a 10.70% year-on-year decline in its consolidated net profit at ₹420.80 Crore for Q4FY25.

22 May 2025|12:15 PM
Read More
Top Stocks for Today - 22nd May 2025

Here are some of the stocks that may see significant price movement today: NBCC, IndusInd Bank, Hindustan Zinc, etc.

22 May 2025|06:38 AM
Read More
Mankind Pharma Faces ₹183.11 Crore Tax Demand

The cumulative demand, including interest charges, is ₹183.11 crore.

30 Mar 2025|04:34 PM
Read More
Mankind Pharma Merges Three Subsidiaries

The merger took effect on March 29, 2025, after all necessary regulatory approvals were obtained.

30 Mar 2025|01:33 PM
Read More
Mankind Pharma Faces ₹111.68 Crore Tax Demand, Plans to Appeal

The tax adjustments pertain to Section 80IC/80IE, which involves deductions for businesses in special economic zones, and a disallowance of certain expenditures under Section 37(1) of the Act.

28 Feb 2025|11:13 PM
Read More
Top Stocks for Today - 24th January 2025

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

24 Jan 2025|07:50 AM
Read More
Mankind Pharma Q3 Profit Falls 16%, Revenue Jumps 24%

The company reported a good growth in EBITDA of 36.8% to ₹830 crore in the quarter against ₹606.5 crore in Q3 FY24.

23 Jan 2025|11:57 PM
Read More
Mankind Pharma Secures ₹5,000 Crore NCDs by Pledging 56.31% Stake in BSV

The NCDs issued are categorized, rated, secured, redeemable, and transferable, distributed across three series.

8 Jan 2025|04:01 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.